1521
vs
H
Hang Seng (Hong Kong)
1521
Over the past 12 months, Frontage Holdings Corp has underperformed Hang Seng (Hong Kong), delivering a return of -35% compared to the Hang Seng (Hong Kong)'s +31% growth.
Stocks Performance
1521 vs Hang Seng (Hong Kong)
Performance Gap
1521 vs Hang Seng (Hong Kong)
Performance By Year
1521 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Frontage Holdings Corp
Glance View
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.